BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19752004)

  • 1. Essential thrombocythemia transforming into acute biphenotypic leukemia in a patient on hydroxyurea monotherapy.
    Sandhu G; Ranade A; Siddiqi S; Balderacchi JL
    Ann Oncol; 2009 Nov; 20(11):1899-900. PubMed ID: 19752004
    [No Abstract]   [Full Text] [Related]  

  • 2. Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?
    Marcellino B; Hoffman R; Mascarenhas J
    Leuk Res; 2019 Jan; 76():94-95. PubMed ID: 30501902
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.
    Furgerson JL; Vukelja SJ; Baker WJ; O'Rourke TJ
    Am J Hematol; 1996 Feb; 51(2):137-40. PubMed ID: 8579054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow failure due to T-cell large granular lymphocytic leukemia in a patient with essential thrombocythemia.
    Selvan SR; Sheehy PF; Heinemann FS; Anbuganapathi S
    Leuk Res; 2011 Feb; 35(2):278-82. PubMed ID: 20934219
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute biphenotypic leukemia arising in a patient with essential thrombocythemia.
    Wong GC; Lee LH
    Am J Hematol; 2006 Aug; 81(8):624-6. PubMed ID: 16823822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia.
    Azagury M; Martelli JM; Morcelet M; Duboucher C; Flandrin G
    Leuk Lymphoma; 2003 Jun; 44(6):1067-9. PubMed ID: 12854912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential thrombocythemia and acute leukemia.
    Ferrari D; Ticozzelli G; De Vizzi M; Corigliano P; De Vizzi G
    Haematologica; 1993; 78(6):401-2. PubMed ID: 8175035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of hydroxyurea in patients with essential thrombocythemia.
    Finazzi G; Barbui T
    Pathol Biol (Paris); 2001 Mar; 49(2):167-9. PubMed ID: 11317964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When and how to treat essential thrombocythemia.
    Barbui T; Finazzi G
    N Engl J Med; 2005 Jul; 353(1):85-6. PubMed ID: 16000360
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyurea-Induced Oral Hyperpigmentation: A Case Report and Review of the Literature.
    Veillet-Lemay G; Haber RM
    J Cutan Med Surg; 2019; 23(1):111-113. PubMed ID: 30232899
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea.
    van den Anker-Lugtenburg PJ; Sizoo W
    Am J Hematol; 1990 Feb; 33(2):152. PubMed ID: 2301374
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
    Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
    N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancies in patients with essential thrombocythaemia.
    Randi ML; Fabris F; Girolami A
    Br J Haematol; 2002 Mar; 116(4):923-4. PubMed ID: 11886403
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
    Iványi JL; Marton É; Plander M; Szendrei T
    Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving management of essential thrombocythaemia.
    Barbui T
    Eur J Haematol Suppl; 2007 Oct; (68):22-3. PubMed ID: 17727561
    [No Abstract]   [Full Text] [Related]  

  • 16. Dysplasia of all granulocyte lineages in myelodysplastic evolution of essential thrombocythemia.
    Bain BJ; Garnett C; Deplano S; Naresh K; Kanfer E
    Am J Hematol; 2013 May; 88(5):426. PubMed ID: 23460316
    [No Abstract]   [Full Text] [Related]  

  • 17. Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
    Sironi M; Bertola G; Lodato A; Spinelli M; Sciariada L
    Acta Haematol; 2003; 109(3):161-2. PubMed ID: 12714827
    [No Abstract]   [Full Text] [Related]  

  • 18. Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia.
    Demirçay Z; Cömert A; Adigüzel C
    Int J Dermatol; 2002 Dec; 41(12):872-4. PubMed ID: 12492973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia and myelofibrosis: Simultaneous transformation of essential thrombocythemia during treatment with hydroxyurea.
    Nalluru SS; Efe O; Chen Y; Trivedi N
    J Cancer Res Ther; 2022; 18(4):1180-1182. PubMed ID: 36149183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia.
    Quintás-Cardama A; Pérez-Encinas M; Gonzalez S; Bendaña A; Bello JL
    Ann Hematol; 1999 Apr; 78(4):187-8. PubMed ID: 10348150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.